Transgenic expression of human neutrophil peptide-1 enhances hepatic fibrosis in mice fed a choline-deficient, L-amino acid-defined diet

Liver International

Volumn 33, Issue 10, 2013, Pages 1549-1556

  Ibusuki, Rie ^a   Uto, Hirofumi ^a   Arima, Shiho ^a   Mawatari, Seiichi ^a   Setoguchi, Yoshiko ^a   Iwashita, Yuji ^a   Hashimoto, Shinichi ^a   Maeda, Takuro ^a   Tanoue, Shiro ^a   Kanmura, Shuji ^a   Oketani, Makoto ^a   Ido, Akio ^a   Tsubouchi, Hirohito ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Choline deficient L amino acid defined diet; Hepatic fibrosis; Human neutrophil peptide 1; Nonalcoholic steatohepatitis; Transgenic mice

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA DEFENSIN; ALPHA SMOOTH MUSCLE ACTIN; BETA ACTIN; DEFENSIN 1; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FATTY LIVER; HISTOPATHOLOGY; KUPFFER CELL; LIVER FIBROSIS; MALE; MOUSE; NONALCOHOLIC FATTY LIVER; NONHUMAN; SEROLOGY; STELLATE CELL;

CHOLINE-DEFICIENT L-AMINO ACID-DEFINED DIET; HEPATIC FIBROSIS; HUMAN NEUTROPHIL PEPTIDE-1; NONALCOHOLIC STEATOHEPATITIS; TRANSGENIC MICE;

2,2'-DIPYRIDYL; ALANINE TRANSAMINASE; ALPHA-DEFENSINS; AMINO ACIDS; ANIMALS; AZABICYCLO COMPOUNDS; AZO COMPOUNDS; CELL PROLIFERATION; CHOLINE DEFICIENCY; DIET; FATTY LIVER; HEPATIC STELLATE CELLS; HUMANS; LIVER CIRRHOSIS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC;

EID: 84885174621     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/liv.12203     Document Type: Article

References (41)

1. Salt WB II. Nonalcoholic fatty liver disease (NAFLD): a Comprehensive Review. J Insur Med 2004; 36: 27-41.
2. Bugianesi E, Vanni E, Marchesini G. NASH and the risk of cirrhosis and hepatocellular carcinoma in type 2 diabetes. Curr Diab Rep 2007; 7: 175-80.
3. Cohen JC, Horton JD, Hobbs HH. Human fatty liver disease: old questions and new insights. Science 2011; 332: 1519-23.
4. Rensen SS, Slaats Y, Nijhuis J, et al. Increased hepatic myeloperoxidase activity in obese subjects with nonalcoholic steatohepatitis. Am J Pathol 2009; 175: 1473-82.
5. Wallace K, Burt AD, Wright MC. Liver fibrosis. Biochem J 2008; 411: 1-18.
6. van den Broek I, Sparidans RW, Schellens JH, Beijnen JH. Validation of a quantitative assay for human neutrophil peptide-1, -2, and -3 in human plasma and serum by liquid chromatography coupled to tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2010; 878: 1085-92.
7. Szyk A, Wu Z, Tucker K, et al. Crystal structures of human alpha-defensins HNP4, HD5, and HD6. Protein Sci 2006; 15: 2749-60.
8. Quinn K, Henriques M, Parker T, Slutsky AS, Zhang H. Human neutrophil peptides: a novel potential mediator of inflammatory cardiovascular diseases. Am J Physiol Heart Circ Physiol 2008; 295: H1817-24.
9. Kanmura S, Uto H, Numata M, et al. Human neutrophil peptides 1-3 are useful biomarkers in patients with active ulcerative colitis. Inflamm Bowel Dis 2009; 15: 909-17.
10. Hashimoto S, Uto H, Kanmura S, et al. Human neutrophil peptide-1 aggravates dextran sulfate sodium-induced colitis. Inflamm Bowel Dis 2012; 18: 667-75.
11. Onaga M, Ido A, Hasuike S, et al. Enhanced expression of growth factors and imbalance between hepatocyte proliferation and apoptosis in the livers of rats fed a choline-deficient, L-amino acid -defined diet. Hepatol Res 2004; 28: 94-101.
12. Uematsu F, Takahashi M, Yoshida M, et al. Distinct patterns of gene expression in hepatocellular carcinomas and adjacent non-cancerous, cirrhotic liver tissues in rats fed a choline-deficient, L-amino acid-defined diet. Cancer Sci 2005; 96: 414-24.
13. Aldred PMR, Hollox EJ, Armour JAL. Copy number polymorphism and expression leve variation of the human α-defensin genes DEFA1 and DEFA3. Hum Mol Genet 2005; 14: 2045-52.
14. Chertov O, Michiel DF, Xu L, et al. Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils. J Biol Chem 1996; 271: 2935-40.
15. Arnheiter H. Primary monolayer culture of adult mouse hepatocytes - a model for the study of hepatotropic viruses. Arch Virol 1980; 63: 11-22.
16. Friedman SL, Roll FJ. Isolation and culture of hepatic lipocytes, Kupffer cells, and sinusoidal endothelial cells by density gradient centrifugation with Stractan. Anal Biochem 1987; 161: 207-18.
17. Seki E, De Minicis S, Osterreicher CH, et al. TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med 2007; 13: 1324-32.
18. Takami H, Nishioka K. Raised polyamines in erythrocytes from melanoma-bearing mice and patients with solid tumours. Br J Cancer 1980; 41: 751-6.
19. Mizobe F, Martial E, Colby-Germinario S, Livett BG. An improved technique for the isolation of lymphocytes from small volumes of peripheral mouse blood. J Immunol Methods 1982; 48: 269-79.
20. López-De León A, Rojkind M. A simple micromethod for collagen and total protein determination in formalin-fixed paraffin-embedded sections. J Histochem Cytochem 1985; 33: 737-43.
21. Abe H, Uto H, Takami Y, et al. Transgenic expression of osteoactivin in the liver attenuates hepatic fibrosis in rats. Biochem Biophys Res Commun 2007; 356: 610-5.
22. Yoshiji H, Kuriyama S, Yoshii J, et al. Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats. Hepatology 2001; 34(4 Pt 1): 745-50.
23. Day CP, James OF. Steatohepatitis: a tale of two "hits"? Gastroenterology 1998; 114: 842-5.
24. Rombouts K, Marra F. Molecular mechanisms of hepatic fibrosis in non-alcoholic steatohepatitis. Dig Dis 2010; 28: 229-35.
25. Shanab AA, Scully P, Crosbie O, et al. Small intestinal bacterial overgrowth in nonalcoholic steatohepatitis: association with toll-like receptor 4 expression and plasma levels of interleukin 8. Dig Dis Sci 2011; 56: 1524-34.
26. Lemmers A, Moreno C, Gustot T, et al. The interleukin-17 pathway is involved in human alcoholic liver disease. Hepatology 2009; 49: 646-57.
27. Miller AM, Wang H, Bertola A, et al. Inflammation-associated interleukin-6/signal transducer and activator of transcription 3 activation ameliorates alcoholic and nonalcoholic fatty liver diseases in interleukin-10-deficient mice. Hepatology 2011; 54: 846-56.
28. Grigat J, Soruri A, Forssmann U, Riggert J, Zwirner J. Chemoattraction of macrophages, T lymphocytes, and mast cells is evolutionarily conserved within the human alpha-defensin family. J Immunol 2007; 179: 3958-65.
29. Territo MC, Ganz T, Selsted ME, Lehrer R. Monocyte-chemotactic activity of defensins from human neutrophils. J Clin Invest 1989; 84: 2017-20.
30. Rivera CA, Bradford BU, Hunt KJ, et al. Attenuation of CCl(4)-induced hepatic fibrosis by GdCl(3) treatment or dietary glycine. Am J Physiol Gastrointest Liver Physiol 2001; 281: G200-7.
31. Miura K, Yang L, van Rooijen N, Ohnishi H, Seki E. Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2. Am J Physiol Gastrointest Liver Physiol 2012; 302: G1310-21.
32. Kamari Y, Shaish A, Vax E, et al. Lack of interleukin-1α or interleukin-1β inhibits transformation of steatosis to steatohepatitis and liver fibrosis in hypercholesterolemic mice. J Hepatol 2011; 55: 1086-94.
33. Yoshioka S, Mukae H, Ishii H, et al. Alpha-defensin enhances expression of HSP47 and collagen-1 in human lung fibroblasts. Life Sci 2007; 80: 1839-45.
34. Yamamoto T, Umegae S, Matsumoto K. Daily granulocyte and monocyte adsorptive apheresis in patients with active ulcerative colitis: a prospective safety and feasibility study. J Gastroenterol 2011; 46: 1003-9.
35. Horie Y, Ishii H, Hibi T. Severe alcoholic hepatitis in Japan: prognosis and therapy. Alcohol Clin Exp Res 2005; 29(12 Suppl): 251S-8S.
36. Zhang H, Porro G, Orzech N, et al. Neutrophil defensins mediate acute inflammatory response and lung dysfunction in dose-related fashion. Am J Physiol Lung Cell Mol Physiol 2001; 280: L947-54.
37. Aarbiou J, Verhoosel RM, Van Wetering S, et al. Neutrophil defensins enhance lung epithelial wound closure and mucin gene expression in vitro. Am J Respir Cell Mol Biol 2004; 30: 193-201.
38. van Wetering S, Sterk PJ, Rabe KF, Hiemstra PS. Defensins: key players or bystanders in infection, injury, and repair in the lung? J Allergy Clin Immunol 1999; 104: 1131-8.
39. Klut ME, Whalen BA, Hogg JC. Dynamic changes in neutrophil defensins during endotoxemia. Infect Immun 2001; 69: 7793-9.
40. Lehrer RI, Lichtenstein AK, Ganz T. Defensins: antimicrobial and cytotoxic peptides of mammalian cells. Annu Rev Immunol 1993; 11: 105-28.
41. Bdeir K, Higazi AA, Kulikovskaya I, et al. Neutrophil alpha-defensins cause lung injury by disrupting the capillary-epithelial barrier. Am J Respir Crit Care Med 2010; 181: 935-46.